These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 15579743)
1. A novel circulating hormone of testis origin in humans. Foresta C; Bettella A; Vinanzi C; Dabrilli P; Meriggiola MC; Garolla A; Ferlin A J Clin Endocrinol Metab; 2004 Dec; 89(12):5952-8. PubMed ID: 15579743 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like factor 3: a novel circulating hormone of testicular origin in humans. Ferlin A; Foresta C Ann N Y Acad Sci; 2005 May; 1041():497-505. PubMed ID: 15956751 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. Bay K; Hartung S; Ivell R; Schumacher M; Jürgensen D; Jorgensen N; Holm M; Skakkebaek NE; Andersson AM J Clin Endocrinol Metab; 2005 Jun; 90(6):3410-8. PubMed ID: 15755855 [TBL] [Abstract][Full Text] [Related]
4. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders. Bay K; Andersson AM Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598 [TBL] [Abstract][Full Text] [Related]
5. Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome. Lottrup G; Nielsen JE; Maroun LL; Møller LM; Yassin M; Leffers H; Skakkebæk NE; Rajpert-De Meyts E Hum Reprod; 2014 Aug; 29(8):1637-50. PubMed ID: 24908673 [TBL] [Abstract][Full Text] [Related]
6. Role of INSL3 and LGR8 in cryptorchidism and testicular functions. Foresta C; Ferlin A Reprod Biomed Online; 2004 Sep; 9(3):294-8. PubMed ID: 15353080 [TBL] [Abstract][Full Text] [Related]
7. Seasonal expression of INSL3 and Lgr8/Insl3 receptor transcripts indicates variable differentiation of Leydig cells in the roe deer testis. Hombach-Klonisch S; Schön J; Kehlen A; Blottner S; Klonisch T Biol Reprod; 2004 Oct; 71(4):1079-87. PubMed ID: 15151926 [TBL] [Abstract][Full Text] [Related]
9. Expression analyses of insulin-like peptide 3, RXFP2, LH receptor, and 3β-hydroxysteroid dehydrogenase in testes of normal and cryptorchid dogs. Hannan MA; Kawate N; Kubo Y; Pathirana IN; Büllesbach EE; Hatoya S; Inaba T; Takahashi M; Tamada H Theriogenology; 2015 Oct; 84(7):1176-84. PubMed ID: 26220663 [TBL] [Abstract][Full Text] [Related]
10. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Anand-Ivell RJ; Relan V; Balvers M; Coiffec-Dorval I; Fritsch M; Bathgate RA; Ivell R Biol Reprod; 2006 May; 74(5):945-53. PubMed ID: 16467492 [TBL] [Abstract][Full Text] [Related]
11. Environmental effects on hormonal regulation of testicular descent. Toppari J; Virtanen H; Skakkebaek NE; Main KM J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):184-6. PubMed ID: 17049842 [TBL] [Abstract][Full Text] [Related]
12. A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development. Chevalier N; Brucker-Davis F; Lahlou N; Coquillard P; Pugeat M; Pacini P; Panaïa-Ferrari P; Wagner-Mahler K; Fénichel P Hum Reprod; 2015 Feb; 30(2):447-53. PubMed ID: 25527819 [TBL] [Abstract][Full Text] [Related]
13. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. Kumagai J; Hsu SY; Matsumi H; Roh JS; Fu P; Wade JD; Bathgate RA; Hsueh AJ J Biol Chem; 2002 Aug; 277(35):31283-6. PubMed ID: 12114498 [TBL] [Abstract][Full Text] [Related]
14. The novel hormone INSL3 is expressed in human testicular Leydig cell tumors: a clinical and immunohistochemical study. Rossato M; Tavolini IM; Calcagno A; Gardiman M; Dal Moro F; Artibani W Urol Oncol; 2011; 29(1):33-7. PubMed ID: 19110449 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients. Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism. Bay K; Virtanen HE; Hartung S; Ivell R; Main KM; Skakkebaek NE; Andersson AM; ; Toppari J J Clin Endocrinol Metab; 2007 Oct; 92(10):4020-7. PubMed ID: 17666478 [TBL] [Abstract][Full Text] [Related]
17. Biological role and clinical significance of insulin-like peptide 3. Ivell R; Anand-Ivell R Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):210-6. PubMed ID: 21415739 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like factor 3: where are we now? Ivell R; Hartung S; Anand-Ivell R Ann N Y Acad Sci; 2005 May; 1041():486-96. PubMed ID: 15956750 [TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like factor 3 hormone-receptor system in the reproductive organs of male goats. Pitia AM; Minagawa I; Uera N; Hamano K; Sugawara Y; Nagura Y; Hasegawa Y; Oyamada T; Sasada H; Kohsaka T Cell Tissue Res; 2015 Nov; 362(2):407-20. PubMed ID: 26017634 [TBL] [Abstract][Full Text] [Related]
20. Human testicular insulin-like factor 3 and endocrine disrupters. Bay K; Anand-Ivell R Vitam Horm; 2014; 94():327-48. PubMed ID: 24388196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]